AzTrials
AzTrials

Pulpitis - IrreversibleNCT05582317

Efficacy of Combination of Biodentine and Simvastatin as a Pulp Capping Materials in Vital Pulpotomy of Primary Molars

A study testing Biodentine and Simvastatin in people with Pulpitis - Irreversible, run by Suez Canal University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Objective: This study was conducted to evaluate the efficacy of combination of biodentine with simvastatin as a pulpotomy agent for vital primary molars clinically and radiographically. Read more about this study

Who is it for?
Ages 4 to 7 years
Conditions the study is for
Pulpitis - Irreversible
What is being tested?
Biodentine and Simvastatin
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
23 May 2021to 25 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 7 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Apparently healthy children free from any known systemic diseases.
  • Parent willing to participate in the study and signed an informed consent.
  • Patient had at least three restorable primary molars with a caries- exposed vital pulp

Who cannot join

  • history of spontaneous pain or provoked pain.
  • clinical signs and ̸ or symptoms suggesting a non-vital tooth such as (fistula, sinus tract, soft tissue swelling, mobility or tenderness to percussion).
  • non-Restorable tooth
  • pathologic or physiologic mobility

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of dentistry, Suez canal university

    Ismailia

Other trials in Egypt

About this study

Official title: Efficacy of Combination of Biodentine and Simvastatin as a Pulp Capping Materials in Vital Pulpotomy of Primary Molars: - a Clinical and Experimental Study

Objective: This study was conducted to evaluate the efficacy of combination of biodentine with simvastatin as a pulpotomy agent for vital primary molars clinically and radiographically.

Study design: 60 primary molars in 20 children aged 4-7 years old were randomly allocated to three groups, Biodentine, Simvastatin and combination of Biodentine and simvastatin. Clinical and radiographic examinations were conducted at 1, 3, 6, 9 and 12 months after treatment.

Key words: Pulpotomy, Primary teeth, Biodentine, Simvastatin.

Read the detailed description

Each tooth will be locally anesthetized using topical anesthetic gel benzocaine 20% on the mucosa after drying the area with gauze; the application of local anesthesia using Mepivacaine Hydrocholride 2% with Levonordefrin 1:20000 to the tooth following the recommended technique for each tooth to be treated; then the tooth will be isolated using rubber dam and high suction 3. The pulpotomy procedures will be performed as follow:- All soft caries will be removed by large spoon excavator. Cavity outline will be performed using a sterile #330 carbide bur at high speed (30,000 rpm) contra-angle hand piece will be used under a water coolant.

  • Access to a pulp chamber will be detected with a probe, or if the roof of the pulp chamber is sufficiently thin to see the pulpal tissue. When the pulpal exposure is confirmed, the roof of the pulp chamber will be removed with a sterile large low speed round bur #4 with water spray.
  • The coronal pulp will be amputated using a sterile sharp spoon excavator, until the orifices of the stumps can be seen clearly without remnant tags and the access will be refined with a sterile high speed fissure bur (El sayed et al., 2019).
  • The pulp chamber will be irrigated with normal saline.
  • Pulp hemostasis will be achieved using a wet cotton pellet with sterile saline applied on the radicular pulp stumps under slight pressure for 2 to 3 minutes.
  • If bleeding cant be controlled within 5 minutes, the tooth will be excluded from the study and the needed treatment will be done.
  1. Depending on group allocation, the pulp stumps of molars will be dressed as follows:

Group (I): 20 primary molars were treated with Biodentine :-

The mixture of Biodentine will be made according to manufacturer's directions as follow:

  1. Biodentine is available in the form of a pre-measured capsule and a liquid in a pipette ii. Before the Biodentine capsule is opened, it is tapped gently on a hard surface to diffuse the powder. iii. Five drops of liquid from the single-dose dispenser is poured into the capsule, then it is placed in an amalgamator and mixed for 30 sec . iv. The mixture is recovered with the aid of the manufacturer supplied spatula.
  • The mixture of Biodentine is introduced into the pulp chamber using amalgam carrier, uniformly placed over the floor of pulp chamber and compacted with a condenser

Group (II):20 primary molars were treated with Simvastatin :-

  • Simvastatin powder 1.5 mg is mixed with distilled water to get homogenous paste (Shaheen et al., 2018)
  • The mixture of Simvastatin then iss delivered to into the pulp chamber using a plastic instrument and compacted with a condenser

Group (III): 20 primary molars isre treated with combination of Biodentine and Simvastatin:-

  • 1:1 of mixture of Biodentine and Simvastatin paste, using one measurable instrument, they will be together and the mixture will be delivered to into the pulp chamber using a plastic instrument and compacted with a condenser
  1. In three groups the access cavity of all treated molars is filled by restorative glass ionomer cement and all molars are finally restored with stainless steel crowns and cemented by glass ionomer cement
  2. Post-operative digital radiograph will be taken at the same visit for all treated primary molars (0-baseline) 7. The patients is instructed to perform oral hygiene measures (teeth brushing twice daily) under supervision of their parents.
  3. Clinical follow up will be done after (one, three, six, nine and twelve) months.

Digital Radiographic follow up will be done after (three, six, nine and twelve) months.

Radiographic examination: It will be done by taking aiagnostic pre-operative digital periapical radiograph using size 0 Phosphostimulable Phosphor plates (PSP), scanner and x-ray machine at Oral Radiology Department ,Faculty of Dentistry ,Suez Canal University to assess the inclusion and exclusion criteria.

  1. The patient is asked to come to the clinic between follow up visits if he/she has any complain from the treatment, and the alternative treatment will be done according to the case.

A.II.7: Methods of Evaluation:

The pulpotomized teeth are judged as clinically and radiographically successful if they met the following criteria (Elbardissy et al., 2019).

Clinically:

Absence of pain. No tender on percussion. No swelling/sinus. No pathological tooth mobility.

Radiographically:

No loss of lamina dura. Normal periodontal ligament space. No external/internal resorption. No periapical /furcation radiolucency. Evaluation will be done by two independent evaluators Treatment is considered as clinically failure when one or more of the following signs (pain, tender on percussion swelling/sinus or pathological tooth mobility) were detected and radiographically failure when one or more of the following signs (lamina dura, widening in periodontal ligament space presence of external/internal resorption or presence of periapical /furcation radiolucency) were detected . Time for teeth with pulpotomy failure was defined as the time elapsed between treatment and the first visit in which pathologic finding was detected. When failure was detected, the tooth was traditionally treated with zinc oxide eugenol pulpectomy or extracted and excluded from the study

Being tested
Biodentine, Simvastatin

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BiodentineDrug

    Tricalcium silicate, dicalcium silicate, calcium carbonate and oxide filler, iron oxide shade and zirconium oxide

  • SimvastatinDrug

    3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

Study groups in NCT05582317
Study groupRoleWhat they receive
BiodentineActive comparator20 primary molars were treated by Biodentine
Receives: Drug: Biodentine
SimvastatinActive comparator20 primary molars were treated by Biodentine
Receives: Drug: Simvastatin
combination of Biodentine and SimvastatinActive comparator20 primary molars were treated by Biodentine
Receives: Drug: Biodentine; Drug: Simvastatin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical assessment

    Pain, tenderness, Swelling No tender on percussion. No swelling/sinus. No pathological tooth mobility.

    Measured: 12 months

Secondary outcomes (1)
  1. Radiographically:

    Lamina dura, periodontal ligament space, resorption Normal periodontal ligament space. No external/internal resorption. No periapical /furcation radiolucency.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Oct 2022
  2. Study start23 May 2021
  3. Primary completion24 May 2022
  4. Study completion25 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05582317
Sponsor's protocol ID
2020-293
Status last verified
Aug 2022
First submitted
12 Sep 2022
Last updated
17 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Biodentine and Simvastatin in people with Pulpitis - Irreversible, run by Suez Canal University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical assessment (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in